RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:563

Peripartum cardiomyopathy

low confidenceDisorder

Also known as: Postpartum cardiomyopathy

Publications

4,981

Trials

6

Interventional, condition-specific

Researchers

1,148

Distinct authors in sample

Gene link

—

Readiness

4/6

Stages with a signal

Clinical definition (Orphanet)

Peripartum (PPCM) is an , potentially fatal form of dilated that develops during the final month of pregnancy or within five months after delivery.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (2)

peripartum cardiomyopathy · postpartum cardiomyopathy

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

4/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    4,981 matched papers (3,332 in last 10 years) Source

  3. Phenotype characterisedPresent

    43 HPO annotations (e.g. Tachycardia; Left ventricular hypertrophy; Reduced left ventricular ejection fraction) Source

  4. Animal modelPresent

    1 genotype model (Mus musculus) Source

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialPresent

    6 matched on ClinicalTrials.gov (2 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

43

Associated phenotypes · MONDO:0018920

  • Tachycardia
  • Left ventricular hypertrophy
  • Reduced left ventricular ejection fraction
  • Orthopnea
  • Left ventricular systolic dysfunction

Showing 5 of 43 — open Monarch for the full list.

Animal models (Monarch / Alliance)

1

Model associations linked to this Mondo ID

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

13

Drugs / clinical candidates · MONDO_0018920

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

4,981

4,981 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

4,981 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

3,332 in the last 10 years · low confidence

Phrase hits: 4,981 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,148

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Sliwa K14 papers · 2026

    Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

    Papers in Europe PMC
  2. 02
    Bauersachs J10 papers · 2026

    Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

    Papers in Europe PMC
  3. 03
    Hoevelmann J6 papers · 2026

    Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

    Papers in Europe PMC
  4. 04
    van der Meer P5 papers · 2026

    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

    Papers in Europe PMC
  5. 05
    Viljoen C5 papers · 2026

    Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

    Papers in Europe PMC
  6. 06
    Chakafana G4 papers · 2026

    Department of Chemistry and Biochemistry, Hampton University, Hampton, VA, USA.

    Papers in Europe PMC
  7. 07
    Hilfiker-Kleiner D4 papers · 2026

    Institute Cardiovascular Complications in Pregnancy and Oncologic Therapies, Philipps University Marburg, Marburg, Germany.

    Papers in Europe PMC
  8. 08
    Karaye KM4 papers · 2026

    Department of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.

    Papers in Europe PMC
  9. 09
    Rakisheva A4 papers · 2026

    Qonaev City Hospital, Almaty Region, Kazakhstan.

    Papers in Europe PMC
  10. 10
    Damasceno A3 papers · 2026

    Eduardo Mondlane University, Maputo, Mozambique.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

6

interventional trials for this specific condition

6 interventional trials matched this specific condition name; 2 currently recruiting in our sample.

Data as of 11 September 2026

6 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 90.1th percentile).

low confidence · 90.1th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

6 interventional trials matched after quoted-phrase search and title/condition post-filter.

Observational and natural-history studies

8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 3 · after dedupe 3 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 3 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Uncertain / not reviewed (3)

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Peripartum cardiomyopathy — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Peripartum cardiomyopathy" OR "Postpartum cardiomyopathy"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Peripartum cardiomyopathy" OR "Postpartum cardiomyopathy"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 6 interventional · 8 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (4981) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity

Ingested 2026-07-26T14:21:24.182Z